AP1465A - Gardos channel antagonists. - Google Patents

Gardos channel antagonists.

Info

Publication number
AP1465A
AP1465A APAP/P/2001/002268A AP2001002268A AP1465A AP 1465 A AP1465 A AP 1465A AP 2001002268 A AP2001002268 A AP 2001002268A AP 1465 A AP1465 A AP 1465A
Authority
AP
ARIPO
Prior art keywords
channel antagonists
gardos channel
potassium flux
inhibitors
suprising
Prior art date
Application number
APAP/P/2001/002268A
Other languages
English (en)
Other versions
AP2001002268A0 (en
Inventor
Grant Andrew Mcnaughton-Smith
Gregory Cooksey Rigdon
Jonathan Walter Stocker
Original Assignee
Icagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icagen Inc filed Critical Icagen Inc
Publication of AP2001002268A0 publication Critical patent/AP2001002268A0/xx
Application granted granted Critical
Publication of AP1465A publication Critical patent/AP1465A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/2001/002268A 1999-02-23 2000-02-10 Gardos channel antagonists. AP1465A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13551199P 1999-02-23 1999-02-23
US09/386,601 US6288122B1 (en) 1999-02-23 1999-08-31 Gardos channel antagonists
PCT/US2000/003663 WO2000050026A1 (en) 1999-02-23 2000-02-10 Gardos channel antagonists

Publications (2)

Publication Number Publication Date
AP2001002268A0 AP2001002268A0 (en) 2001-09-30
AP1465A true AP1465A (en) 2005-09-22

Family

ID=26833406

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002268A AP1465A (en) 1999-02-23 2000-02-10 Gardos channel antagonists.

Country Status (16)

Country Link
US (1) US6288122B1 (enExample)
EP (1) EP1158971B1 (enExample)
JP (2) JP4038337B2 (enExample)
KR (1) KR100705726B1 (enExample)
CN (1) CN1193748C (enExample)
AP (1) AP1465A (enExample)
AT (1) ATE370728T1 (enExample)
AU (1) AU762039B2 (enExample)
BR (1) BR0008416A (enExample)
CA (1) CA2371857C (enExample)
DE (1) DE60036093T2 (enExample)
ES (1) ES2291191T3 (enExample)
HK (1) HK1045262B (enExample)
IL (2) IL145012A0 (enExample)
OA (1) OA11838A (enExample)
WO (1) WO2000050026A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
ATE400551T1 (de) 2002-01-04 2008-07-15 Neurosearch As Kaliumkanal-modulatoren
WO2003074038A1 (en) * 2002-02-28 2003-09-12 Icagen, Inc. Methods for treating diseases related to intraocular pressure
WO2005003143A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Novel potassium channel modulators
WO2005003094A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Diarylmethyl derivatives as potassium channel modulators
US7709533B2 (en) * 2005-02-01 2010-05-04 Icagen, Inc. Imines as ion channel modulators
CN101437403A (zh) * 2005-12-20 2009-05-20 Icagen公司 使用三芳基甲烷化合物的治疗方法
US20100056637A1 (en) * 2005-12-20 2010-03-04 Icagen, Inc. Treatment methods using triaryl methane compounds
JP2010536827A (ja) 2007-08-24 2010-12-02 ノイロサーチ アクティーゼルスカブ ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体
US20090076157A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched senicapoc
KR101896430B1 (ko) 2008-04-09 2018-09-10 세루스 코포레이션 적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
US9428568B2 (en) 2008-11-10 2016-08-30 Boehringer Ingelheim International Gmbh Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
US10179115B2 (en) 2015-02-20 2019-01-15 The Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3106155A1 (en) 2015-06-15 2016-12-21 Universite d'Aix Marseille Treatment and diagnosis of hereditary xerocytosis
US11439607B2 (en) * 2016-10-25 2022-09-13 Paracelsus Neuroscience I, LLC Use of senicapoc for treatment of neuropathic pain
WO2018162426A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment and diagnosis of hereditary xerocytosis
WO2020198939A1 (zh) * 2019-03-29 2020-10-08 深圳仁泰医药科技有限公司 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用
US12186286B2 (en) * 2019-07-29 2025-01-07 Paracelsus Neuroscience Llc Use of senicapoc for treatment of stroke
EP4181908A4 (en) * 2020-07-14 2024-03-06 Adimabio LLC COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES
CN116847838A (zh) 2020-12-11 2023-10-03 桑昆专利有限公司 炎症性贫血的治疗和预防

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034589A1 (en) * 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034589A1 (en) * 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease

Also Published As

Publication number Publication date
IL145012A0 (en) 2002-06-30
CN1344158A (zh) 2002-04-10
HK1045262B (zh) 2005-07-29
JP4038337B2 (ja) 2008-01-23
KR20020002393A (ko) 2002-01-09
CA2371857A1 (en) 2000-08-31
DE60036093T2 (de) 2008-05-15
US6288122B1 (en) 2001-09-11
AU2880700A (en) 2000-09-14
IL145012A (en) 2006-12-10
EP1158971A1 (en) 2001-12-05
CN1193748C (zh) 2005-03-23
EP1158971B1 (en) 2007-08-22
HK1045262A1 (en) 2002-11-22
KR100705726B1 (ko) 2007-04-11
WO2000050026A1 (en) 2000-08-31
CA2371857C (en) 2008-07-29
AP2001002268A0 (en) 2001-09-30
EP1158971A4 (en) 2003-04-16
OA11838A (en) 2005-08-22
JP2007262075A (ja) 2007-10-11
ES2291191T3 (es) 2008-03-01
JP2002537331A (ja) 2002-11-05
AU762039B2 (en) 2003-06-19
DE60036093D1 (de) 2007-10-04
ATE370728T1 (de) 2007-09-15
BR0008416A (pt) 2002-01-29

Similar Documents

Publication Publication Date Title
AP1465A (en) Gardos channel antagonists.
GEP20084461B (en) New derivative of 3,3- diphenyl-propylamine
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
GB9818916D0 (en) Use
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
NO20010309L (no) Ikke-peptidiske midler for inhibering av gonatropinfrigjörende hormoner, samt fremgangsmåter og mellomprodukter til fremstilling derav
PL338352A1 (en) Derivatives of 1-(n-phenylaminoalkyl)-piperazine substituted at position 2 of its phenyl ring
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
AU2003267203A8 (en) Method for administering thermotherapy to prevent the growth of tumors
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
WO2000056774A8 (en) Methods of using bioelastomers
EA200101046A1 (ru) Производные индигоидных бис-индолов
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
ATE276770T1 (de) Dopamin und serotonin transport-ligande und bilderzeugungsmitteln
ATE293691T1 (de) Myostatin genpromoter und inhibierung dessen aktivierung
EA200401622A1 (ru) Способы лечения ангиогенеза, роста опухолей и метастазов
DE60206272D1 (de) Chelatorkonjugate mit verbesserten eigenschaften
AU6769801A (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
EA200200545A1 (ru) Онколитические комбинации для лечения рака
BG105710A (en) 5ht1 antagonists for antidepressant therapy
EA200400692A1 (ru) Антагонисты хемокинного рецептора и способы их применения
EA200200798A1 (ru) Кальцилитические соединения
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
AU2002214657A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica